T2 Biosystems to Present at the Canaccord Genuity Growth Conference
July 30 2019 - 7:30AM
T2 Biosystems, Inc. (the “Company”) (NASDAQ:TTOO), a leader in the
development and commercialization of innovative medical diagnostic
products for critical unmet needs in healthcare, announced today
that John Sprague, Chief Financial Officer, and Tom Lowery, Chief
Scientific Officer, are scheduled to present at the 39th Annual
Canaccord Genuity Growth Conference. The conference is being held
on August 7-8 at the InterContinental Hotel in Boston,
Massachusetts.
Mr. Sprague and Dr. Lowery are scheduled to present on
Wednesday, August 7, 2019 at 4:30-4:55 p.m. ET. Mr. Sprague and Dr.
Lowery will be available for one-on-one meetings during the
conference. The presentation will be webcast live and available for
replay, and may be accessed by visiting the Investors/Events &
Presentations section of the Company’s website
at www.t2biosystems.com. A replay of the webcast will be
available shortly after the conclusion of the presentation and will
be archived on the Company's website for 90 days following the
presentation.
About T2 Biosystems: T2 Biosystems, a leader in
the development and commercialization of innovative medical
diagnostic products for critical unmet needs in healthcare, is
dedicated to improving patient care and reducing the cost of care
by helping clinicians effectively treat patients faster than ever
before. T2 Biosystems’ products include the T2Dx® Instrument,
T2Candida® Panel, and T2Bacteria® Panel, and are powered by the
proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems
has an active pipeline of future products, including products for
the detection of additional species and antibiotic resistance
markers of sepsis pathogens, and tests for Lyme disease.
Media Contact: Gina Kent, Vault Communications
gkent@vaultcommunications.com 610-455-2763
Investor Contact: Zack Kubow, W2O Group
zkubow@w2ogroup.com 415-658-6436
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Mar 2024 to Apr 2024
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Apr 2023 to Apr 2024